Publications by authors named "Rajneesh Nath"

Claim this Profile
O
Outcomes of adults older than 70 years of age undergoing allogeneic stem cell transplantation.
Ishan Bhatia, Shyam Patel, Laurie Pearson, Kayal Parthiban, Sakiko Suzuki, Muthalagu Ramanathan, Jonathan Gerber, Rajneesh Nath

Leuk Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study.
Alison Sehgal, Daanish Hoda, Peter A Riedell, Nilanjan Ghosh, Mehdi Hamadani, Rajneesh Nath

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.
Fateeha Furqan, Kwang W Ahn, Manmeet Kaur, Jinalben Patel, Stephen Ansell, Rajneesh Nath

Am J Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies.
Frederick L Locke, Javier L Munoz, Michael T Tees, Lazaros J Lekakis, Sven de Vos, Rajneesh Nath

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase III SIERRA Trial of I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah Choe, Mark R Litzow

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frameshift Mutations in Leukemia-Associated Genes Correlate With Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia.
Emma Cammann, Sindha Madhav, Lloyd Hutchinson, Jan Cerny, Muthalagu Ramanathan, Rajneesh Nath

J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20 B Cell Lymphoma.
Javier Munoz, Ian W Flinn, Jonathon B Cohen, Jessica Sachs, Benjamin Exter, Rajneesh Nath

Transplant Cell Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
Renata Ferrarotto, Paul L Swiecicki, Dan P Zandberg, Robert A Baiocchi, Robert Wesolowski, Rajneesh Nath

Oral Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results.
Sham Mailankody, Jeffrey V Matous, Saurabh Chhabra, Michaela Liedtke, Surbhi Sidana, Rajneesh Nath

Nat Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
Tanya Siddiqi, David G Maloney, Saad S Kenderian, Danielle M Brander, Kathleen Dorritie, Rajneesh Nath

Lancet· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Ella J Ariza-Heredia, Drew J Winston, Scott D Rowley, Kathleen Mullane, Pranatharthi Chandrasekar, Rajneesh Nath

Open Forum Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid/lymphoid neoplasm with rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations.
Dong Chen, Guang Liu, Michael R Lewis, Xia Li, Matthew Ulrickson, Rajneesh Nath

Leuk Res Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results.
Sham Mailankody, Jeffrey V Matous, Saurabh Chhabra, Michaela Liedtke, Surbhi Sidana, Rajneesh Nath

Nat Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Alison Sehgal, Daanish Hoda, Peter A Riedell, Nilanjan Ghosh, Mehdi Hamadani, Rajneesh Nath

Lancet Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pretransplant mutation status on survival after allogeneic stem cell transplant for acute myeloid leukemia.
William Selove, Lloyd Hutchinson, Vladislav Makarenko, Xiuling Meng, Keith Tomaszewicz, Muthalagu Ramanathan, Rajneesh Nath

EJHaem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study.
Roy F Chemaly, Lynn El Haddad, Drew J Winston, Scott D Rowley, Kathleen M Mulane, Pranatharthi Chandrasekar, Rajneesh Nath

Clin Infect Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
Zheng Zhou, Rajneesh Nath, Jan Cerny, Hai-Lin Wang, Mei-Jie Zhang, Sunita Nathan

Blood Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma.
Ravi Vij, Rajneesh Nath, Daniel E H Afar, María-Victoria Mateos, Jesús G Berdeja

Clin Cancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based ("5 + 1") induction chemotherapy regimen in newly diagnosed acute myeloid leukemia.
Neeraj Y Saini, Jan Cerny, Vanessa F Furtado, Angela Desmond, Zheng Zhou, Muthalagu Ramanathan, Rajneesh Nath

Am J Hematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination.
Neeraj Saini, Rajneesh Nath, Jan Cerny

Ann Hematol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.
Robert F Cornell, Anita D'Souza, Adetola A Kassim, Luciano J Costa, Racquel D Innis-Shelton, Rajneesh Nath, Muthalagu Ramanathan

Biol Blood Marrow Transplant· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Properdin Levels in Individuals with Chemotherapy-Induced Neutropenia.
Artsiom Tsyrkunou, Sarika Agarwal, Bibek Koirala, Robert W Finberg, Rajneesh Nath

Open Forum Infect Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitoxantrone-Induced Cardiotoxicity in Acute Myeloid Leukemia-A Velocity Vector Imaging Analysis.
Amir Y Shaikh, Sourabh Suryadevara, Abhishek Tripathi, Mohamed Ahmed, Jennifer L Kane, Rajneesh Nath, Muthalagu Ramanathan

Echocardiography· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unilateral Eye Findings: A Rare Herald of Acute Leukemia.
Avni V Patel, John B Miller, Rajneesh Nath, Helen A Shih, Michael K Yoon

Ocul Oncol Pathol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
Parameswaran Hari, Omar S Aljitawi, Carlos Arce-Lara, Rajneesh Nath, Natalie Callander

Biol Blood Marrow Transplant· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis